With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.50982-12-2,Dichloro(cycloocta-1,5-diene)ruthenium(II),as a common compound, the synthetic route is as follows.
A solution of (tBu2PCH2CH2)2NH (1 .0 g, 2.77 mmol) was added to [RuCl2(cod)]n (0.775 g, 2.77 mmol) and the resulting suspension stirred for 4 hours underargon. This was followed by the addition of 4-methoxyphenyl isonitrile (368 mg,2.77 mmol) and the mixture refluxed for 15 hours under argon. It was cooled to room temperature and ether (40 ml) added, and the suspension stirred for 1 hour at room temperature. It was filtered, washed with ether and dried under vacuum. Yield = 1 .44 g. X-ray quality crystals were obtained by slow diffusion of ether into a CH2CI2 solution of the compound.
The synthetic route of 50982-12-2 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; HADEED, Gerald, S.; ABDUR-RASHID, Kamaluddin; (61 pag.)WO2018/193401; (2018); A1;,
Highly efficient and robust molecular ruthenium catalysts for water oxidation
Catalysts | Special Issue : Ruthenium Catalysts – MDPI